Golden State Equity Partners’s Gilead Sciences GILD Stock Holding History

Golden State Equity Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.69M	Buy	+69,520	New	+$9.74M	0.73%	18
2024 Q4	–	Sell	-1,034	Closed	-$86.7K	–	612
2024 Q3	$86.7K	Buy	+1,034	New	+$78.9K	0.05%	298
2023 Q4	$208K	Sell	2,564 -265	-9%	-$20.6K	0.05%	339
2023 Q3	$212K	Buy	+2,829	New	+$218K	0.06%	306
2021 Q4	–	Sell	-10,030	Closed	-$701K	–	208
2021 Q3	$701K	Sell	10,030 -4,506	-31%	-$317K	0.29%	88
2021 Q2	$1M	Sell	14,536 -2,547	-15%	-$170K	0.39%	65
2021 Q1	$1.1M	Buy	+17,083	New	+$1.1M	0.63%	44

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Golden State Equity Partners's GILD Position: Q1 2026 in Review

Golden State Equity Partners opened a new position in Gilead Sciences (GILD) in Q1 2026: 69,520 shares worth $9.69M. The stake represents 0.73% of the portfolio and ranks #18 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in GILD as recently as Q3 2024.

Golden State Equity Partners first reported a position in GILD in Q1 2021 and has held it in 7 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Golden State Equity Partners held 69,520 shares of Gilead Sciences worth $9.69M as of Q1 2026.
Gilead Sciences was a new Golden State Equity Partners position in Q1 2026.
Gilead Sciences made up 0.73% of Golden State Equity Partners's portfolio in Q1 2026, its #18 holding.
Golden State Equity Partners first reported a position in Gilead Sciences in Q1 2021 and has held it in 7 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.